Citi lowered the firm’s price target on Kenvue (KVUE) to $19 from $20 and keeps a Neutral rating on the shares. The firm adjusted targets in the beverages, household and personal care group as part of a Q1 preview. Investor focus will be on the sector’s margin risk amid higher oil prices and many commodities, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KVUE:
- Kenvue price target lowered to $18 from $19 at Barclays
- Kenvue Inc call volume above normal and directionally bullish
- Kenvue price target lowered to $18 from $19 at UBS
- Kenvue price target raised to $19 from $18 at Barclays
- Judge spurns Kenvue bid to dismiss Texas lawsuit over Tylenol, Reuters reports
